Xact

CareFusion Corporation Launches International Jazz Festival Series

...ralia), Oct. 3 - 5, 2009 CareFusion Jazz Festival Paris, Oct. 16 - 2 4 , 2009 CareFusion New York Jazz Festival, June 2010 ( e xact dates to be determined) As part of the Festival Series, CareFusion will broadcast live to hospitals the performances of select f...

Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery

... treated with carotid stents in Abbott's CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) and EXACT(TM) (Emboshield and xact Post Approval Carotid Stent Trial) post-marketing trials, which enrolled 4,111 patients, demonstrated 30 day patient outcome results that are comparab...

Xact in Medical Technology

Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiology's 56th Annual Scientific Session

...e at high risk for carotid artery surgery. Clinical outcome data for Abbott's Emboshield BareWire(TM) Rapid Exchange Embolic Protection System and xact Rapid Exchange Carotid Stent System and ACCULINK(TM) Carotid Stent System and ACCUNET(TM) Embolic Protection System will be reported. Late-Bre...

Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke

...al) settings in patients who are not favorable candidates for surgery. Interim results from the first 1,500 patients enrolled in EXACT (Emboshield and xact Post Approval Carotid Stent Trial) and from the first 600 patients enrolled in CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare...

Xact in Medical Products

Xact Carotid Stent

Description:... The xact stent is self-expanding and has a closed-cell design that creates a tightly...m a diseased vessel when it is treated, which can lead to stroke. The xact stent is designed for use in combination with the fully retractable Emboshi...
Company:Abbott Vascular

Xact in Biological News

2 carotid artery stenting studies show results comparable to AHA guidelines

...ients treated with carotid stents in Abbotts CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) and EXACT (Emboshield and xact Post Approval Carotid Stent Trial) post-marketing trials, which enrolled 4,111 patients in over 150 sites, demonstrated 30 day patient outcome results...